Human urinary concentrations of monoisononyl phthalate estimated using physiologically based pharmacokinetic modeling and experimental pharmacokinetics in humanized-liver mice orally administered with diisononyl phthalate

References

• Adachi K, Suemizu H, Murayama N, et al. (2015). Human biofluid concentrations of mono(2-ethylhexyl)phthalate extrapolated from pharmacokinetics in chimeric mice with humanized liver administered with di(2-ethylhexyl)phthalate and physiologically based pharmacokinetic modeling. Environ Toxicol Pharmacol 39:1067–73.
   PubMed Web of Science ®Google Scholar
• Berry LM, Li C, Zhao Z. (2011). Species differences in distribution and prediction of human V(ss) from preclinical data. Drug Metab Dispos 39:2103–16.
   PubMed Web of Science ®Google Scholar
• Choi K, Joo H, Campbell JL Jr, et al. (2012). In vitro metabolism of di(2-ethylhexyl) phthalate (DEHP) by various tissues and cytochrome P450s of human and rat. Toxicol in Vitro 26:315–22.
   PubMed Web of Science ®Google Scholar
• Dekant W, Bridges J. (2016). Assessment of reproductive and developmental effects of DINP, DnHP and DCHP using quantitative weight of evidence. Regul Toxicol Pharmacol 81:397–406.
   PubMed Web of Science ®Google Scholar
• Emoto C, Murayama N, Rostami-Hodjegan A, Yamazaki H. (2009). Utilization of estimated physicochemical properties as an integrated part of predicting hepatic clearance in the early drug-discovery stage: Impact of plasma and microsomal binding. Xenobiotica 39:227–35.
   PubMed Web of Science ®Google Scholar
• European Food Safety Authority (EFSA) (2005). Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to di-isononylphthalate (DINP) for use in food contact materials. EFSA J 3:244.
   Google Scholar
• Hasegawa M, Kawai K, Mitsui T, et al. (2011). The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem Biophys Res Commun 405:405–10.
   PubMed Web of Science ®Google Scholar
• Hellwig J, Freudenberger H, Jackh R. (1997). Differential prenatal toxicity of branched phthalate esters in rats. Food Chem Toxicol 35:501–12.
   PubMed Web of Science ®Google Scholar
• Herr C, Zur NA, Koch HM, et al. (2009). Urinary di(2-ethylhexyl)phthalate (DEHP)–metabolites and male human markers of reproductive function. Int J Hyg Environ Health 212:648–53.
   PubMed Web of Science ®Google Scholar
• Hsu JY, Hsu JF, Chen YR, et al. (2016). Urinary exposure marker discovery for toxicants using ultra-high pressure liquid chromatography coupled with Orbitrap high resolution mass spectrometry and three untargeted metabolomics approaches. Anal Chim Acta 939:73–83.
   PubMed Web of Science ®Google Scholar
• Kluwe WM, Haseman JK, Huff JE. (1983). The carcinogenicity of di(2-ethylhexyl) phthalate (DEHP) in perspective. J Toxicol Environ Health 12:159–69.
   PubMed Web of Science ®Google Scholar
• Koch HM, Angerer J. (2007). Di-iso-nonylphthalate (DINP) metabolites in human urine after a single oral dose of deuterium-labelled DINP. Int J Hyg Environ Health 210:9–19.
   PubMed Web of Science ®Google Scholar
• Koch HM, Becker K, Wittassek M, et al. (2007). Di-n-butylphthalate and butylbenzylphthalate – urinary metabolite levels and estimated daily intakes: pilot study for the German Environmental Survey on children. J Expo Sci Environ Epidemiol 17:378–87.
   PubMed Web of Science ®Google Scholar
• Koch HM, Preuss R, Angerer J. (2006). Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure - an update and latest results. Int J Androl 29:155–65.
   PubMed Web of Science ®Google Scholar
• Koch HM, Ruther M, Schutze A, et al. (2017). Phthalate metabolites in 24-h urine samples of the German Environmental Specimen Bank (ESB) from 1988 to 2015 and a comparison with US NHANES data from 1999 to 2012. Int J Hyg Environ Health 220:130–41.
   PubMed Web of Science ®Google Scholar
• Kransler KM, Bachman AN, McKee RH. (2012). A comprehensive review of intake estimates of di-isononyl phthalate (DINP) based on indirect exposure models and urinary biomonitoring data. Regul Toxicol Pharmacol 62:248–56.
   PubMed Web of Science ®Google Scholar
• Kurata Y, Makinodan F, Shimamura N, Katoh M. (2012a). Metabolism of di (2-ethylhexyl) phthalate (DEHP): comparative study in juvenile and fetal marmosets and rats. J Toxicol Sci 37:33–49.
   PubMed Web of Science ®Google Scholar
• Kurata Y, Shimamura N, Katoh M. (2012b). Metabolite profiling and identification in human urine after single oral administration of DEHP. J Toxicol Sci 37:401–14.
   PubMed Web of Science ®Google Scholar
• Miyaguchi T, Suemizu H, Shimizu M, et al. (2015). Human urine and plasma concentrations of bisphenol A extrapolated from pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and semi-physiological pharmacokinetic modeling. Regul Toxicol Pharmacol 72:71–6.
   PubMed Web of Science ®Google Scholar
• Nishiyama S, Suemizu H, Shibata N, et al. (2015). Simulation of human plasma concentrations of thalidomide and primary 5-hydroxylated metabolites explored with pharmacokinetic data in humanized TK-NOG mice. Chem Res Toxicol 28:2088–90.
   PubMed Web of Science ®Google Scholar
• Rhodes C, Orton TC, Pratt IS, et al. (1986). Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man. Environ Health Persp 65:299–307.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Suemizu H, Mitsui M, et al. (2017). Metabolic profiles of pomalidomide in human plasma simulated with pharmacokinetic data in control and humanized-liver mice. Xenobiotica 47:844–8.
   PubMed Web of Science ®Google Scholar
• Suemizu H, Sota S, Kuronuma M, et al. (2014). Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes. Regul Toxicol Pharmacol 70:468–73.
   PubMed Web of Science ®Google Scholar
• Tsukada A, Suemizu H, Murayama N, et al. (2013). Plasma concentrations of melengestrol acetate in humans extrapolated from the pharmacokinetics established in in vivo experiments with rats and chimeric mice with humanized liver and physiologically based pharmacokinetic modeling. Regul Toxicol Pharmacol 65:316–24.
   PubMed Web of Science ®Google Scholar
• Utoh M, Suemizu H, Mitsui M, et al. (2016). Human plasma concentrations of cytochrome P450 probe cocktails extrapolated from pharmacokinetics in mice transplanted with human hepatocytes and from pharmacokinetics in common marmosets using physiologically based pharmacokinetic modeling. Xenobiotica 46:1049–55.
   PubMed Web of Science ®Google Scholar
• Yamashita M, Suemizu H, Murayama N, et al. (2014). Human plasma concentrations of herbicidal carbamate molinate extrapolated from the pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and physiologically based pharmacokinetic modeling. Regul Toxicol Pharmacol 70:214–21.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Suemizu H, Mitsui M, et al. (2016). Combining chimeric mice with humanized liver, mass spectrometry, and physiologically-based pharmacokinetic modeling in toxicology. Chem Res Toxicol 29:1903–11.
   PubMed Web of Science ®Google Scholar
• Zeman FA, Boudet C, Tack K, et al. (2013). Exposure assessment of phthalates in French pregnant women: results of the ELFE pilot study. Int J Hyg Environ Health 216:271–9.
   PubMed Web of Science ®Google Scholar